Urokinase biosimilar - Tasly PharmaceuticalAlternative Names: Recombinant human urokinase - Tasly Pharmaceuticals; rhPro-uk - Tasly Pharmaceuticals
Latest Information Update: 27 Apr 2016
At a glance
- Originator Tasly Pharmaceuticals, Inc.
- Class Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasminogen activators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Myocardial infarction
Most Recent Events
- 21 Nov 2011 Launched for Myocardial infarction in China (IV)